Free Trial
$100 Off Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 Now
Claim MarketBeat All Access Sale Promotion

Mesa Laboratories (MLAB) Competitors

Mesa Laboratories logo
$108.64 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$108.64 +0.00 (+0.00%)
As of 05/22/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MLAB vs. VPG, DAKT, COHR, CGNX, and OSIS

Should you buy Mesa Laboratories stock or one of its competitors? MarketBeat compares Mesa Laboratories with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Mesa Laboratories include Vishay Precision Group (VPG), Daktronics (DAKT), Coherent (COHR), Cognex (CGNX), and OSI Systems (OSIS). These companies are all part of the "electronic equipment & instruments" industry.

How does Mesa Laboratories compare to Vishay Precision Group?

Mesa Laboratories (NASDAQ:MLAB) and Vishay Precision Group (NYSE:VPG) are both small-cap electronic equipment & instruments companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.

Mesa Laboratories has a beta of 0.94, meaning that its stock price is 6% less volatile than the broader market. Comparatively, Vishay Precision Group has a beta of 1.13, meaning that its stock price is 13% more volatile than the broader market.

90.6% of Mesa Laboratories shares are owned by institutional investors. Comparatively, 87.6% of Vishay Precision Group shares are owned by institutional investors. 4.9% of Mesa Laboratories shares are owned by company insiders. Comparatively, 7.6% of Vishay Precision Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Vishay Precision Group has a net margin of 1.85% compared to Mesa Laboratories' net margin of 1.51%. Mesa Laboratories' return on equity of 22.02% beat Vishay Precision Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Mesa Laboratories1.51% 22.02% 8.86%
Vishay Precision Group 1.85%2.28%1.66%

Vishay Precision Group has higher revenue and earnings than Mesa Laboratories. Mesa Laboratories is trading at a lower price-to-earnings ratio than Vishay Precision Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mesa Laboratories$240.98M2.49-$1.97M$0.64169.75
Vishay Precision Group$307.20M4.93$5.29M$0.45252.90

Mesa Laboratories currently has a consensus target price of $94.00, indicating a potential downside of 13.48%. Vishay Precision Group has a consensus target price of $83.67, indicating a potential downside of 26.48%. Given Mesa Laboratories' higher probable upside, analysts plainly believe Mesa Laboratories is more favorable than Vishay Precision Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mesa Laboratories
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Vishay Precision Group
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.00

In the previous week, Vishay Precision Group had 7 more articles in the media than Mesa Laboratories. MarketBeat recorded 9 mentions for Vishay Precision Group and 2 mentions for Mesa Laboratories. Mesa Laboratories' average media sentiment score of 0.91 beat Vishay Precision Group's score of 0.70 indicating that Mesa Laboratories is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mesa Laboratories
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Vishay Precision Group
3 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Vishay Precision Group beats Mesa Laboratories on 11 of the 17 factors compared between the two stocks.

How does Mesa Laboratories compare to Daktronics?

Daktronics (NASDAQ:DAKT) and Mesa Laboratories (NASDAQ:MLAB) are both small-cap electronic equipment & instruments companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

Daktronics has a beta of 1.67, suggesting that its stock price is 67% more volatile than the broader market. Comparatively, Mesa Laboratories has a beta of 0.94, suggesting that its stock price is 6% less volatile than the broader market.

Mesa Laboratories has a consensus price target of $94.00, suggesting a potential downside of 13.48%. Given Mesa Laboratories' stronger consensus rating and higher possible upside, analysts clearly believe Mesa Laboratories is more favorable than Daktronics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Daktronics
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Mesa Laboratories
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

Mesa Laboratories has lower revenue, but higher earnings than Daktronics. Daktronics is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Daktronics$756.48M1.30-$10.12M$0.5536.89
Mesa Laboratories$240.98M2.49-$1.97M$0.64169.75

Daktronics has a net margin of 3.43% compared to Mesa Laboratories' net margin of 1.51%. Mesa Laboratories' return on equity of 22.02% beat Daktronics' return on equity.

Company Net Margins Return on Equity Return on Assets
Daktronics3.43% 16.55% 8.82%
Mesa Laboratories 1.51%22.02%8.86%

61.7% of Daktronics shares are held by institutional investors. Comparatively, 90.6% of Mesa Laboratories shares are held by institutional investors. 5.3% of Daktronics shares are held by insiders. Comparatively, 4.9% of Mesa Laboratories shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Daktronics had 1 more articles in the media than Mesa Laboratories. MarketBeat recorded 3 mentions for Daktronics and 2 mentions for Mesa Laboratories. Daktronics' average media sentiment score of 1.17 beat Mesa Laboratories' score of 0.91 indicating that Daktronics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Daktronics
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Mesa Laboratories
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Mesa Laboratories beats Daktronics on 9 of the 15 factors compared between the two stocks.

How does Mesa Laboratories compare to Coherent?

Mesa Laboratories (NASDAQ:MLAB) and Coherent (NYSE:COHR) are both electronic equipment & instruments companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, media sentiment, analyst recommendations, institutional ownership and risk.

In the previous week, Coherent had 11 more articles in the media than Mesa Laboratories. MarketBeat recorded 13 mentions for Coherent and 2 mentions for Mesa Laboratories. Mesa Laboratories' average media sentiment score of 0.91 beat Coherent's score of 0.23 indicating that Mesa Laboratories is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mesa Laboratories
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Coherent
4 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Mesa Laboratories has a beta of 0.94, meaning that its share price is 6% less volatile than the broader market. Comparatively, Coherent has a beta of 2.05, meaning that its share price is 105% more volatile than the broader market.

Coherent has a net margin of 7.10% compared to Mesa Laboratories' net margin of 1.51%. Mesa Laboratories' return on equity of 22.02% beat Coherent's return on equity.

Company Net Margins Return on Equity Return on Assets
Mesa Laboratories1.51% 22.02% 8.86%
Coherent 7.10%9.67%5.01%

Coherent has higher revenue and earnings than Mesa Laboratories. Mesa Laboratories is trading at a lower price-to-earnings ratio than Coherent, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mesa Laboratories$240.98M2.49-$1.97M$0.64169.75
Coherent$5.81B12.71$49.36M$2.09180.56

90.6% of Mesa Laboratories shares are owned by institutional investors. Comparatively, 83.3% of Coherent shares are owned by institutional investors. 4.9% of Mesa Laboratories shares are owned by company insiders. Comparatively, 0.5% of Coherent shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Mesa Laboratories currently has a consensus target price of $94.00, indicating a potential downside of 13.48%. Coherent has a consensus target price of $379.64, indicating a potential upside of 0.60%. Given Coherent's stronger consensus rating and higher possible upside, analysts clearly believe Coherent is more favorable than Mesa Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mesa Laboratories
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Coherent
0 Sell rating(s)
6 Hold rating(s)
15 Buy rating(s)
1 Strong Buy rating(s)
2.77

Summary

Coherent beats Mesa Laboratories on 12 of the 17 factors compared between the two stocks.

How does Mesa Laboratories compare to Cognex?

Cognex (NASDAQ:CGNX) and Mesa Laboratories (NASDAQ:MLAB) are both electronic equipment & instruments companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk and valuation.

Cognex has higher revenue and earnings than Mesa Laboratories. Cognex is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cognex$994.36M11.06$114.44M$0.8478.68
Mesa Laboratories$240.98M2.49-$1.97M$0.64169.75

Cognex has a beta of 1.48, suggesting that its stock price is 48% more volatile than the broader market. Comparatively, Mesa Laboratories has a beta of 0.94, suggesting that its stock price is 6% less volatile than the broader market.

88.1% of Cognex shares are held by institutional investors. Comparatively, 90.6% of Mesa Laboratories shares are held by institutional investors. 1.7% of Cognex shares are held by company insiders. Comparatively, 4.9% of Mesa Laboratories shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Cognex has a net margin of 13.62% compared to Mesa Laboratories' net margin of 1.51%. Mesa Laboratories' return on equity of 22.02% beat Cognex's return on equity.

Company Net Margins Return on Equity Return on Assets
Cognex13.62% 10.89% 8.09%
Mesa Laboratories 1.51%22.02%8.86%

Cognex pays an annual dividend of $0.34 per share and has a dividend yield of 0.5%. Mesa Laboratories pays an annual dividend of $0.64 per share and has a dividend yield of 0.6%. Cognex pays out 40.5% of its earnings in the form of a dividend. Mesa Laboratories pays out 100.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cognex has raised its dividend for 10 consecutive years.

Cognex currently has a consensus price target of $69.36, indicating a potential upside of 4.94%. Mesa Laboratories has a consensus price target of $94.00, indicating a potential downside of 13.48%. Given Cognex's stronger consensus rating and higher probable upside, analysts plainly believe Cognex is more favorable than Mesa Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cognex
0 Sell rating(s)
7 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.67
Mesa Laboratories
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

In the previous week, Cognex had 7 more articles in the media than Mesa Laboratories. MarketBeat recorded 9 mentions for Cognex and 2 mentions for Mesa Laboratories. Mesa Laboratories' average media sentiment score of 0.91 beat Cognex's score of 0.91 indicating that Mesa Laboratories is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cognex
5 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Mesa Laboratories
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Cognex beats Mesa Laboratories on 13 of the 20 factors compared between the two stocks.

How does Mesa Laboratories compare to OSI Systems?

Mesa Laboratories (NASDAQ:MLAB) and OSI Systems (NASDAQ:OSIS) are both electronic equipment & instruments companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings, valuation and media sentiment.

Mesa Laboratories currently has a consensus target price of $94.00, indicating a potential downside of 13.48%. OSI Systems has a consensus target price of $294.00, indicating a potential upside of 32.37%. Given OSI Systems' stronger consensus rating and higher probable upside, analysts clearly believe OSI Systems is more favorable than Mesa Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mesa Laboratories
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
OSI Systems
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86

OSI Systems has a net margin of 8.42% compared to Mesa Laboratories' net margin of 1.51%. Mesa Laboratories' return on equity of 22.02% beat OSI Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Mesa Laboratories1.51% 22.02% 8.86%
OSI Systems 8.42%18.84%7.13%

In the previous week, OSI Systems had 4 more articles in the media than Mesa Laboratories. MarketBeat recorded 6 mentions for OSI Systems and 2 mentions for Mesa Laboratories. Mesa Laboratories' average media sentiment score of 0.91 beat OSI Systems' score of 0.34 indicating that Mesa Laboratories is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mesa Laboratories
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
OSI Systems
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

90.6% of Mesa Laboratories shares are held by institutional investors. Comparatively, 89.2% of OSI Systems shares are held by institutional investors. 4.9% of Mesa Laboratories shares are held by insiders. Comparatively, 4.3% of OSI Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

OSI Systems has higher revenue and earnings than Mesa Laboratories. OSI Systems is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mesa Laboratories$240.98M2.49-$1.97M$0.64169.75
OSI Systems$1.81B2.03$149.64M$8.7625.35

Mesa Laboratories has a beta of 0.94, meaning that its share price is 6% less volatile than the broader market. Comparatively, OSI Systems has a beta of 1.31, meaning that its share price is 31% more volatile than the broader market.

Summary

OSI Systems beats Mesa Laboratories on 9 of the 16 factors compared between the two stocks.

Get Mesa Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MLAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MLAB vs. The Competition

MetricMesa LaboratoriesMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$599.69M$6.97B$6.43B$12.32B
Dividend Yield0.59%1.68%2.76%5.28%
P/E Ratio169.7547.4521.0025.66
Price / Sales2.4984.61580.1798.33
Price / Cash8.8624.9143.4956.67
Price / Book3.696.5310.377.14
Net Income-$1.97M$158.81M$3.57B$335.98M
7 Day Performance7.28%3.72%6.00%3.56%
1 Month Performance10.90%0.74%3.51%2.54%
1 Year Performance-1.10%3.17%34.12%35.05%

Mesa Laboratories Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MLAB
Mesa Laboratories
2.721 of 5 stars
$108.64
flat
$94.00
-13.5%
-1.1%$599.69M$240.98M169.75680
VPG
Vishay Precision Group
3.1931 of 5 stars
$85.88
+28.9%
$53.67
-37.5%
+338.0%$1.14B$307.20M214.692,100
DAKT
Daktronics
2.6329 of 5 stars
$20.49
-0.9%
N/A+31.9%$989.67M$756.48M37.252,702
COHR
Coherent
3.454 of 5 stars
$374.40
-1.4%
$361.88
-3.3%
+380.6%$73.25B$5.81B179.1430,216
CGNX
Cognex
4.3734 of 5 stars
$65.68
-2.3%
$68.86
+4.8%
+122.4%$10.93B$994.36M78.192,745

Related Companies and Tools


This page (NASDAQ:MLAB) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners